Yabao Pharmaceutical Group Co Ltd Strategic Asset Allocation Index

Latest as of June 2023: 42.9%

Yabao Pharmaceutical Group Co Ltd strategic asset allocation index. Yabao Pharmaceutical Group Co Ltd (600351) has a Strategic Asset Allocation Index of 42.9% as of June 2023. Strategic assets (PP&E of CN¥1.32 Billion plus long-term investments of CN¥-) total CN¥1.32 Billion, measured against net assets of CN¥3.06 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 600351 equity to assets ratio to measure how much of total assets are equity-financed.

SAAI

42.9%
Strategic Assets / Net Assets

Strategic Assets

CN¥1.32 Billion
PP&E + LT Investments

PP&E

CN¥1.32 Billion
CNY

Net Assets

CN¥3.06 Billion
CNY

Strategic Asset Allocation Index of Yabao Pharmaceutical Group Co Ltd (2000–2022)

Strategic asset allocation index of Yabao Pharmaceutical Group Co Ltd from 2000 to 2022. This chart shows how Yabao Pharmaceutical Group Co Ltd's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 42.9%, representing strategic assets of CN¥1.32 Billion against net assets of CN¥3.06 Billion CNY. Check 600351 tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Yabao Pharmaceutical Group Co Ltd Strategic Asset Allocation Index by Year (2000–2022)

Yabao Pharmaceutical Group Co Ltd strategic asset allocation index by year from 2000 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Yabao Pharmaceutical Group Co Ltd from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Yabao Pharmaceutical Group Co Ltd market capitalisation.

Year SAAI Strategic Assets (CNY) PP&E LT Investments Net Assets Change (pp)
2022 45.8% CN¥1.38 Billion CN¥1.38 Billion CN¥- CN¥3.01 Billion ▼ -3.3 pp
2021 49.1% CN¥1.45 Billion CN¥1.45 Billion CN¥- CN¥2.96 Billion ▼ -6.4 pp
2020 55.5% CN¥1.56 Billion CN¥1.56 Billion CN¥- CN¥2.82 Billion ▼ -5.6 pp
2019 61.1% CN¥1.66 Billion CN¥1.66 Billion CN¥- CN¥2.72 Billion ▲ +0.2 pp
2018 60.9% CN¥1.83 Billion CN¥1.74 Billion CN¥93.89 Million CN¥3.01 Billion ▼ -5.3 pp
2017 66.2% CN¥1.93 Billion CN¥1.83 Billion CN¥95.45 Million CN¥2.91 Billion ▼ -6.9 pp
2016 73.1% CN¥2.00 Billion CN¥1.93 Billion CN¥71.05 Million CN¥2.73 Billion ▲ +0.4 pp
2015 72.7% CN¥1.95 Billion CN¥1.88 Billion CN¥71.05 Million CN¥2.68 Billion ▼ -29.6 pp
2014 102.3% CN¥1.86 Billion CN¥1.86 Billion CN¥- CN¥1.82 Billion ▼ -1.9 pp
2013 104.2% CN¥1.77 Billion CN¥1.77 Billion CN¥- CN¥1.70 Billion ▲ +6.4 pp
2012 97.8% CN¥1.58 Billion CN¥1.58 Billion CN¥- CN¥1.62 Billion ▼ -17.3 pp
2011 115.1% CN¥1.33 Billion CN¥1.33 Billion CN¥- CN¥1.16 Billion ▼ -2.6 pp
2010 117.6% CN¥1.18 Billion CN¥1.18 Billion CN¥- CN¥1.00 Billion ▲ +11.0 pp
2009 106.6% CN¥958.86 Million CN¥958.86 Million CN¥- CN¥899.55 Million ▲ +38.9 pp
2008 67.7% CN¥561.98 Million CN¥561.98 Million CN¥- CN¥830.32 Million ▼ -95.2 pp
2007 162.9% CN¥619.08 Million CN¥619.08 Million CN¥- CN¥380.08 Million ▼ -23.7 pp
2006 186.6% CN¥624.14 Million CN¥624.14 Million CN¥- CN¥334.54 Million ▼ -2.5 pp
2005 189.0% CN¥669.85 Million CN¥669.85 Million CN¥- CN¥354.37 Million ▲ +58.5 pp
2004 130.5% CN¥441.24 Million CN¥441.24 Million CN¥- CN¥338.16 Million ▲ +66.3 pp
2003 64.2% CN¥204.23 Million CN¥204.23 Million CN¥- CN¥318.26 Million ▲ +23.0 pp
2002 41.2% CN¥114.44 Million CN¥114.44 Million CN¥- CN¥277.81 Million ▼ -61.8 pp
2001 103.0% CN¥94.57 Million CN¥94.57 Million CN¥- CN¥91.84 Million ▲ +8.2 pp
2000 94.8% CN¥81.15 Million CN¥81.15 Million CN¥- CN¥85.64 Million —
pp = percentage points